{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:03:41Z","timestamp":1780535021322,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Colon cancer stem cells have been attributed to poor prognosis, therapeutic resistance and aggressive nature of the malignancy. Recent reports associated CD44v6 expression with relapse, metastasis and reduced 5-year survival of colon cancer patients, thereby making it a potential therapeutic target. Thus, in this study, comprehensive prediction and screening of CD44v6 against 1674 lead compounds was conducted. Silibinin was identified as a potential compound targeting CD44v6. Inorder to substantiate these findings, the cytotoxic effect of 5FU, Silibinin and 5FU+ Silibinin was assessed on human colon carcinoma cell line HCT116 derived CD44+ subpopulation. 5FU+ Silibinin inhibited cell proliferation of CD44+ subpopulation at lower concentration than Silibinin standalone. Further, corresponding to CD44v6 knockdown cells, 5FU+ Silibinin treatment significantly decreased CD44v6, Nanog, CTNNB1 and CDKN2A expression whereas increased E-cadherin expression in HCT116 derived CD44+ cells. Moreover, synergistic effect of these drugs suppressed sphere formation, inhibited cell migration, triggered PARP cleavage and perturbation in mitochondrial membrane potential, thereby activating intrinsic apoptotic pathways and induced autophagic cell death. Importantly, 5FU+ Silibinin could inhibit PI3K\/MAPK dual activation and arrest the cell cycle at G0\/G1 phase. Thus, our study suggests that inhibition of CD44v6 attenuates stemness of colon cancer stem cells and holds a prospect of potent therapeutic target.<\/jats:p>","DOI":"10.1038\/s41598-018-35069-0","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T10:37:39Z","timestamp":1542105459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Shanaya","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargav","family":"Waghela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanisha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foram","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheefa","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandramani","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"35069_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/cncr.24760","volume":"116","author":"BK Edwards","year":"2010","unstructured":"Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975\u20132006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 116, 544\u2013573 (2010).","journal-title":"Cancer."},{"key":"35069_CR2","unstructured":"Stewart, B.W. & Wild, C.P. editors. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer (2014)."},{"key":"35069_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader, J. E. & Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer. 8, 755\u201368 (2008).","journal-title":"Nature Reviews Cancer."},{"key":"35069_CR4","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1200\/JCO.2008.17.6941","volume":"26","author":"BM Boman","year":"2008","unstructured":"Boman, B. M. & Huang, E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol. 26, 2828\u20132838 (2008).","journal-title":"J Clin Oncol."},{"key":"35069_CR5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00109-009-0518-4","volume":"87","author":"L Ricci-Vitiani","year":"2009","unstructured":"Ricci-Vitiani, L., Fabrizi, E., Palio, E. & De Maria, R. Colon cancer stem cells. J Mol Med. 87, 1097\u20131104 (2009).","journal-title":"J Mol Med."},{"key":"35069_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fimmu.2015.00154","volume":"6","author":"V Orian-Rousseau","year":"2015","unstructured":"Orian-Rousseau, V. CD44 acts as a signalling platform controlling tumor progression and metastasis. Front Immunol. 6, 154 (2015).","journal-title":"Front Immunol."},{"key":"35069_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133, 704\u2013715 (2008).","journal-title":"Cell."},{"key":"35069_CR8","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/nar\/21.5.1225","volume":"21","author":"C Tol\u0308g","year":"1993","unstructured":"To lg, C., Hofmann, M., Herrlich, P. & Ponta, H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21, 1225\u20131229 (1993).","journal-title":"Nucleic Acids Res."},{"key":"35069_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","volume":"14","author":"M Todaro","year":"2014","unstructured":"Todaro, M. et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 14, 342\u2013356 (2014).","journal-title":"Cell Stem Cell."},{"key":"35069_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3892\/or.2013.2273","volume":"29","author":"S Saito","year":"2013","unstructured":"Saito, S. et al. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncol Rep. 29, 1570\u20131578 (2013).","journal-title":"Oncol Rep."},{"key":"35069_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/PPO.0b013e3181629a67","volume":"14","author":"J Peng","year":"2008","unstructured":"Peng, J. et al. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Cancer J. 14, 54\u201361 (2008).","journal-title":"Cancer J."},{"key":"35069_CR12","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.18632\/oncotarget.2068","volume":"5","author":"S Kumar","year":"2014","unstructured":"Kumar, S., Raina, K., Agarwal, C. & Agarwal, R. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4\/6-mediated survival signals. Oncotarget. 5, 4972\u20134989 (2014).","journal-title":"Oncotarget."},{"key":"35069_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.pathol.2.010506.091847","volume":"2","author":"RJ Ward","year":"2007","unstructured":"Ward, R. J. & Dirks, P. B. Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol. 2, 175\u2013189 (2007).","journal-title":"Annu Rev Pathol."},{"key":"35069_CR14","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/bies.20679","volume":"29","author":"I Sanchez-Garcia","year":"2007","unstructured":"Sanchez-Garcia, I., Vicente-Duenas, C. & Cobaleda, C. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice? Bioessays. 29, 1269\u20131280 (2007).","journal-title":"Bioessays."},{"key":"35069_CR15","first-page":"37","volume":"8","author":"A Hospital","year":"2015","unstructured":"Hospital, A., Go\u00f1i, J. R., Orozco, M. & Gelp\u00ed, J. L. Molecular dynamics simulations: advances and applications. Adv Appl Bioinform Chem. 8, 37\u201347 (2015).","journal-title":"Adv Appl Bioinform Chem."},{"key":"35069_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2, 161\u2013174 (2002).","journal-title":"Nat Rev Cancer."},{"key":"35069_CR17","doi-asserted-by":"publisher","first-page":"e0141919","DOI":"10.1371\/journal.pone.0141919","volume":"10","author":"H An","year":"2015","unstructured":"An, H. et al. Salinomycin Promotes Anoikis and Decreases the CD44+\/CD24\u2212 Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells. PLoS One. 10, e0141919 (2015).","journal-title":"PLoS One."},{"key":"35069_CR18","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s10495-011-0631-z","volume":"16","author":"H Kauntz","year":"2011","unstructured":"Kauntz, H., Bousserouel, S., Goss\u00e9, F. & Raul, F. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells. Apoptosis. 16, 1042\u20131053 (2011).","journal-title":"Apoptosis."},{"key":"35069_CR19","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1158\/1541-7786.MCR-11-0156","volume":"9","author":"JM Louderbough","year":"2011","unstructured":"Louderbough, J. M. & Schroeder, J. A. Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res. 9, 1573\u20131586 (2011).","journal-title":"Mol Cancer Res."},{"key":"35069_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/0008-5472.CAN-11-1831","volume":"72","author":"NP Judd","year":"2012","unstructured":"Judd, N. P. et al. ERK1\/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res. 72, 365\u201374 (2012).","journal-title":"Cancer Res."},{"key":"35069_CR21","first-page":"11","volume":"14","author":"B B\u00e1nky","year":"2012","unstructured":"B\u00e1nky, B. et al. Characteristics of CD44 alternative splice pattern in course of human colorectal adenocarcinoma progression. Mol Cancer. 14, 11\u201383 (2012).","journal-title":"Mol Cancer."},{"key":"35069_CR22","first-page":"1421","volume":"59","author":"CW Fan","year":"2012","unstructured":"Fan, C. W. et al. Prognostic significance of relevant markers of cancer stem cells in colorectal cancer - a meta-analysis. Hepatogastroenterology. 59, 1421\u20131427 (2012).","journal-title":"Hepatogastroenterology."},{"key":"35069_CR23","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.18632\/oncotarget.7084","volume":"7","author":"JY Zhou","year":"2016","unstructured":"Zhou, J. Y. et al. Role of CD44(high)\/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer. Oncotarget. 7, 7657\u20137666 (2016).","journal-title":"Oncotarget."},{"key":"35069_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1756283X08093607","volume":"1","author":"JM Carethers","year":"2008","unstructured":"Carethers, J. M. Systemic Treatment of Advanced Colorectal Cancer: Tailoring Therapy to the Tumor. Therap Adv Gastroenterol. 1, 33\u201342 (2008).","journal-title":"Therap Adv Gastroenterol."},{"key":"35069_CR25","first-page":"3767","volume":"31","author":"S Kim","year":"2011","unstructured":"Kim, S. et al. Silibinin suppresses EGFR ligand induced CD44 expression through inhibition of EGFR activity in breast cancer cells. Anticancer Res. 31, 3767\u201373 (2011).","journal-title":"Anticancer Res."},{"key":"35069_CR26","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/stem.1182","volume":"30","author":"EE Ibrahim","year":"2012","unstructured":"Ibrahim, E. E. et al. Embryonic NANOG activity de nes colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms. Stem Cells. 30, 2076\u20132087 (2012).","journal-title":"Stem Cells."},{"key":"35069_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/cbt.9.4.10666","volume":"9","author":"HM Meng","year":"2010","unstructured":"Meng, H. M. et al. Overexpression of Nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer biology & therapy. 9, 295\u2013302 (2010).","journal-title":"Cancer biology & therapy."},{"key":"35069_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/hep.25745","volume":"56","author":"J Shan","year":"2012","unstructured":"Shan, J. et al. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology. 56, 1004\u20131014 (2012).","journal-title":"Hepatology."},{"key":"35069_CR29","doi-asserted-by":"publisher","first-page":"e94621","DOI":"10.1371\/journal.pone.0094621","volume":"9","author":"SH Sahlberg","year":"2014","unstructured":"Sahlberg, S. H., Spiegelberg, D., Glimelius, B., Stenerl\u00f6w, B. & Nestor, M. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS One. 9, e94621 (2014).","journal-title":"PLoS One."},{"key":"35069_CR30","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1038\/sj.onc.1207158","volume":"22","author":"C Agarwal","year":"2003","unstructured":"Agarwal, C. et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene. 22, 8271\u20138282 (2003).","journal-title":"Oncogene."},{"key":"35069_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.4252\/wjsc.v6.i5.606","volume":"6","author":"S Mikhail","year":"2014","unstructured":"Mikhail, S. & Zeidan, A. Stem cells in gastrointestinal cancers: The road less travelled. World J Stem Cells. 6, 606\u2013613 (2014).","journal-title":"World J Stem Cells."},{"key":"35069_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3892\/ijo.2014.2498","volume":"45","author":"B Xiong","year":"2014","unstructured":"Xiong, B., Ma, L., Hu, X., Zhang, C. & Cheng, Y. Characterization of side population cells isolated from the colon cancer cell line SW480. Int J Oncol. 45, 1175\u20131183 (2014).","journal-title":"Int J Oncol."},{"key":"35069_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1593\/neo.10188","volume":"12","author":"M Kaur","year":"2010","unstructured":"Kaur, M. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of b-catenin-dependent signaling. Neoplasia. 12, 415\u2013424 (2010).","journal-title":"Neoplasia."},{"key":"35069_CR34","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1158\/1535-7163.MCT-09-0304","volume":"8","author":"M Kaur","year":"2009","unstructured":"Kaur, M. et al. Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft. Mol Cancer Ther. 8, 2366\u20132374 (2009).","journal-title":"Mol Cancer Ther."},{"key":"35069_CR35","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri, M. C., Zalckvar, E., Kimchi, A. & Kroemer, G. Self- eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 8, 741\u2013752 (2007).","journal-title":"Nat Rev Mol Cell Biol."},{"key":"35069_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/10286020.2010.540757","volume":"13","author":"WJ Duan","year":"2011","unstructured":"Duan, W. J. et al. Silibinin activated ROS-p38-NF-\u03baB positive feedback and induced autophagic death in human fibrosarcoma HT1080 cells. J Asian Nat Prod Res. 13, 27\u201335 (2011).","journal-title":"J Asian Nat Prod Res."},{"key":"35069_CR37","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3892\/or.2015.3915","volume":"33","author":"K Jiang","year":"2015","unstructured":"Jiang, K. et al. Silibinin, a natural flavonoid, induces autophagy via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3 in human MCF7 breast cancer cells. Oncol Rep. 33, 2711\u20132718 (2015).","journal-title":"Oncol Rep."},{"key":"35069_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbrc.2015.10.143","volume":"468","author":"SH Kim","year":"2015","unstructured":"Kim, S. H. et al. Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells. Biochem Biophys Res Commun. 468, 151\u2013156 (2015).","journal-title":"Biochem Biophys Res Commun."},{"key":"35069_CR39","doi-asserted-by":"crossref","unstructured":"Duan, W. J. et al. Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways. Biol Pharm Bull. 34, 47-53 (2011).","DOI":"10.1248\/bpb.34.47"},{"key":"35069_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.coph.2013.05.018","volume":"13","author":"E Ghiso","year":"2013","unstructured":"Ghiso, E. & Giordano, S. Targeting MET: why, where and how? Curr Opin Pharmacol. 13, 511\u2013518 (2013).","journal-title":"Curr Opin Pharmacol."},{"key":"35069_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","volume":"10","author":"J Rodon","year":"2013","unstructured":"Rodon, J., Dienstmann, R., Serra, V. & Tabernero, J. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol. 10, 143\u2013153 (2013).","journal-title":"Nat Rev Clin Oncol."},{"key":"35069_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1471-2105-6-185","volume":"6","author":"M Margelevicius","year":"2005","unstructured":"Margelevicius, M. & Venclovas, C. PSI-BLAST-ISS: An intermediate sequence search tool for estimation of the position-specific alignment reliability. BMC Bioinformatics. 6, 185\u2013194 (2005).","journal-title":"BMC Bioinformatics."},{"key":"35069_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0076-6879(03)74020-8","volume":"374","author":"A Fiser","year":"2003","unstructured":"Fiser, A. & Sali, A. Modeller: Generation and refinement of homology-based protein structure models. Methods in Enzymology. 374, 461\u2013491 (2003).","journal-title":"Methods in Enzymology."},{"key":"35069_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471250953.bi0506s47","volume":"47","author":"B Webb","year":"2014","unstructured":"Webb, B. & Sali, A. Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics. 47, 1\u201332 (2014).","journal-title":"Current Protocols in Bioinformatics."},{"key":"35069_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-2836(63)80023-6","volume":"7","author":"GN Ramachandran","year":"1963","unstructured":"Ramachandran, G. N., Ramakrishnan, C. & Sasisekharan, V. Stereochemistry of polypeptide chain configurations. J Mol Biol. 7, 95\u20139 (1963).","journal-title":"J Mol Biol."},{"key":"35069_CR46","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35, W407\u201310 9 (2007).","journal-title":"Nucleic Acids Res."},{"key":"35069_CR47","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","volume":"277","author":"D Eisenberg","year":"1997","unstructured":"Eisenberg, D., L\u00fcthy, R. & Bowie, J. U. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 277, 396\u2013404 (1997).","journal-title":"Methods Enzymol."},{"key":"35069_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/protein\/15.3.185","volume":"15","author":"MG Pikkemaat","year":"2002","unstructured":"Pikkemaat, M. G., Linssen, A. B., Berendsen, H. J. & Janssen, D. B. Molecular dynamics simulations as a tool for improving protein stability. Protein Eng. 15, 185\u201392 (2002).","journal-title":"Protein Eng."},{"key":"35069_CR49","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/prot.20251","volume":"57","author":"E Krieger","year":"2004","unstructured":"Krieger, E. et al. Making optimal use of empirical energy functions: force-field parameterization in crystal space. Proteins. 57, 678\u201383 (2004).","journal-title":"Proteins."},{"key":"35069_CR50","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcc.10349","volume":"24","author":"Y Duan","year":"2003","unstructured":"Duan, Y. et al. A point charge force field for molecular mechanics simulations of proteins based on condensed phase quantum mechanical calculations. J Comput Chem. 24, 1999\u20132012 (2003).","journal-title":"J Comput Chem."},{"key":"35069_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127\u2013134 (1995).","journal-title":"Protein Eng."},{"key":"35069_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J Mol Graph. 14, 27\u201338 (1996).","journal-title":"J Mol Graph."},{"key":"35069_CR53","doi-asserted-by":"publisher","first-page":"e24217","DOI":"10.1371\/journal.pone.0024217","volume":"6","author":"M Jijiwa","year":"2011","unstructured":"Jijiwa, M. et al. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One. 6, e24217 (2011).","journal-title":"PLoS One."},{"key":"35069_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep22787","volume":"6","author":"K Ranjan","year":"2016","unstructured":"Ranjan, K. & Pathak, C. FADD regulates NF-\u03baB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Sci Rep. 6, 22787 (2016).","journal-title":"Sci Rep."},{"key":"35069_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11010-016-2813-z","volume":"422","author":"K Ranjan","year":"2016","unstructured":"Ranjan, K. & Pathak, C. Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death. Mol Cell Biochem. 422, 135\u2013150 (2016).","journal-title":"Mol Cell Biochem."}],"updated-by":[{"DOI":"10.1038\/s41598-018-36920-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35069-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:32:58Z","timestamp":1671622378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35069-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35069"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35069-0","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-018-36920-0","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"10 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16985"}}